Bioprosthetic Total Artificial Heart Implantation Does Not Induce Chronic Inflammation
- PMID: 36228635
- DOI: 10.1097/MAT.0000000000001820
Bioprosthetic Total Artificial Heart Implantation Does Not Induce Chronic Inflammation
Abstract
The Aeson total artificial heart (A-TAH) has been developed for patients at risk of death from biventricular failure. We aimed to assess the inflammatory status in nine subjects implanted with the A-TAH in kinetics over one year. Laboratory assessment of leukocyte counts, inflammatory cytokines assay, and peripheral blood mononuclear cell collection before and after A-TAH implantation. Leukocyte counts were not significantly modulated according to time after A-TAH implantation (coefficient of the linear mixed effect model with 95% CI, -0.05 (-0.71 to -0.61); p = 0.44). We explored inflammatory cytokine after A-TAH and did not observe, at any time, a modified profile compared to pre-implantation values (all p -values > 0.05). Finally, we compared the distribution of circulating immune cell subpopulations identified based on sequential expression patterns for multiple clusters of differentiation. None of the population explored had significant modulation during the 12-month follow-up (all p -values > 0.05). In conclusion, using a cytokine multiplex assay combined with a flow cytometry approach, we demonstrated the absence of inflammatory signals in peripheral blood over a period of 12 months following A-TAH implantation.
Copyright © ASAIO 2022.
Conflict of interest statement
D.M.S., P.I., Y.P. and I.N. received consulting fees from CARMAT. C.P., C.L., A.C. and P.J. are employed by CARMAT-SAS. Other authors have no conflicts of interest to report.
References
-
- Ankersmit HJ, Tugulea S, Spanier T, et al.: Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet. 354: 550–555, 1999.
-
- Deng MC, Erren M, Tjan TD, et al.: Left ventricular assist system support is associated with persistent inflammation and temporary immunosuppression. Thorac Cardiovasc Surg. 47(suppl 2): 326–331, 1999.
-
- Granja T, Magunia H, Schussel P, Fischer C, Prufer T, Schibilsky D, et al.: Left ventricular assist device implantation causes platelet dysfunction and proinflammatory platelet-neutrophil interaction. Platelets. 33: 132–140, 2022.
-
- Sciaccaluga C, Ghionzoli N, Mandoli GE, et al.: Biomarkers in patients with left ventricular assist device: An insight on current evidence. Biomolecules. 12: 334, 2022.
-
- Woolley JR, Teuteberg JJ, Bermudez CA, et al.: Temporal leukocyte numbers and granulocyte activation in pulsatile and rotary ventricular assist device patients. Artif Organs. 38: 447–455, 2014.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical